Alliancebernstein L.P. Uni Qure N.V. Transaction History

Alliancebernstein L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.71 - $11.83 $628,498 - $1.11 Million	-93,666 Reduced 48.14%	100,916 $677,000
Q2 2023 Aug 15, 2023	SELL	$11.12 - $22.2 $3.14 Million - $6.27 Million	-282,539 Reduced 59.22%	194,582 $2.23 Million
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $578,540 - $713,739	-30,938 Reduced 6.09%	477,121 $9.61 Million
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $3.29 Million - $4.97 Million	181,791 Added 55.72%	508,059 $11.5 Million
Q3 2022 Nov 15, 2022	SELL	$16.98 - $25.54 $3.04 Million - $4.57 Million	-178,888 Reduced 35.41%	326,268 $6.12 Million
Q2 2022 Aug 15, 2022	BUY	$13.15 - $20.45 $2.34 Million - $3.63 Million	177,745 Added 54.29%	505,156 $9.42 Million
Q1 2022 May 13, 2022	BUY	$14.54 - $21.5 $2.76 Million - $4.08 Million	189,980 Added 138.24%	327,411 $5.92 Million
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $1.2 Million - $2.14 Million	59,472 Added 76.29%	137,431 $2.85 Million
Q3 2021 Nov 10, 2021	BUY	$26.01 - $38.22 $1.2 Million - $1.76 Million	46,036 Added 144.21%	77,959 $2.5 Million
Q2 2021 Jul 30, 2021	BUY	$29.97 - $37.17 $956,732 - $1.19 Million	31,923 New	31,923 $983,000
Q1 2021 May 06, 2021	SELL	$29.24 - $42.03 $874,802 - $1.26 Million	-29,918 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$35.35 - $50.67 $1.06 Million - $1.52 Million	29,918 New	29,918 $1.08 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.